Results 121 to 130 of about 21,002 (228)
, 2015 Objectives: Escalating healthcare costs and pharmaceutical spending continue to evolve rapidly. With the aim of curtailing the cost of treatment, there is an increased demand of understanding and applying the pharmacoeconomics principles.
Shafie, Asrul Akmal +2 more
core
THE FEATURES OF METHODOLOGY FOR PHARMACOECONOMICS ANALYSIS OF VACCINATION
, 2015 In this paper gradually showed features of the methodology for conducting of pharmacoeconomics analysis of vaccination. Discribes criteria of selection of performance indicators for various vaccines.
A. Yu. Kulikov, Yu. L. Akimova
core
Pharmacogenomics Conference: "Issues in Drug Development & Pharmacoeconomics"
, 2002 On Tuesday, February 26, 2002, the Consortium on Law and Values hosted the "Pharmacogenomics: The Legal, Ethical and Clinical Challenges" conference.
Consortium on Law and Values in Health, Environment, & the Life Sciences
core
Correction: Balancing Access and Value in Multi‑Indication Medicines: Implications of PD‑(L)1 Broad Listings in Australia. [PDF]
PharmacoeconomicsLuc I, Carter D, Merlin T.
europepmc +1 more source
Obstetric pharmacoeconomics. [PDF]
Expert Rev Pharmacoecon Outcomes ResEke AC, Igbodike EP.
europepmc +1 more source
Correction: Retractions of Health Economic Evaluations: A Systematic Review. [PDF]
Pharmacoecon OpenManalastas EJ +3 more
europepmc +1 more source
What to Expect in 2026-2027: Important Health Economics and Outcomes Research Topics. [PDF]
Clinicoecon Outcomes ResAbraham I +5 more
europepmc +1 more source
Toward Value-Based Reimbursement for Hemophilia A in the UAE: A Multi-Stakeholder Perspective. [PDF]
J Mark Access Health PolicyAl Dallal S +7 more
europepmc +1 more source